cf. New Jersey Vol.9 (corporations: Johnson & Johnson)
When you are living with depression, talking is the first step to getting help. Artist @billiebondscul1 talks about the value of conversation when you or your loved ones are living with depression in @POLITICOEurope: https://t.co/5cRROweLCE #BreakingDepression pic.twitter.com/RNLbgevLXd
— Janssen EMEA (@JanssenEMEA) October 30, 2020
For people living with #psoriasis, scaly plaques, itching and redness can result in feelings of discomfort and unwanted attention. At this year's #EADV congress, we look to the latest research that addresses these symptoms and more #ForThePeaceWithin. pic.twitter.com/U0bQBfKG8q
— Janssen EMEA (@JanssenEMEA) October 30, 2020
As part of #Movember we will be speaking to urology experts Prof. Dr. Ost and Prof. Rouprêt to hear their views on the burden of #prostatecancer, diagnostics and the developments going on in the space.
Keep an eye for these interviews and check out our preview below 👇 pic.twitter.com/dGPaArt7sw
— Janssen EMEA (@JanssenEMEA) October 29, 2020
Today is #WorldPsoriasisDay and this year’s theme is #BeInformed! With so much misunderstanding about this serious condition, there are 5 things Therapy Area Lead for Immunology, Jaime Oliver, thinks everyone should know – read his thoughts here https://t.co/YrOpxY7mNJ #psoriasis pic.twitter.com/9IvNJojZP2
— Janssen EMEA (@JanssenEMEA) October 29, 2020
Scientific solutions are needed to help prevent the #flu and RSV infection. On the latest #IDViewpoints episode, our experts and UTHSC weigh in on preventing #respiratory diseases.
Click to listen and subscribe https://t.co/4dDMhdsm40
— Janssen EMEA (@JanssenEMEA) October 29, 2020
LIVE, today Anouk De Vroey joins Mario Monti @SenatoreMonti with @POLITICOEurope panel to discuss Health care systems post-COVID 19: Pressing Reset #POLITICOHCsystems Check out Anouk's latest publication: https://t.co/7TwmRJAXXQ pic.twitter.com/pR57G20rlF
— Janssen EMEA (@JanssenEMEA) October 28, 2020
How do you ensure that patients stay safe while making sure #clinicaltrial data remain useful during a pandemic? Our Therapy Area Lead for #Immunology, Jaime Oliver, describes our patient-centric response to this major global challenge on LinkedIn: https://t.co/MNeUzp2ENP #EADV
— Janssen EMEA (@JanssenEMEA) October 27, 2020
We are #MovingFourth in #HIV with the launch of a new white paper – outlining steps for HCPs to Ask & Measure when considering HIV patients’ QoL. Read the paper https://t.co/oNqoG56HFm #MakeHIVHistory pic.twitter.com/RnLuQzzIx1
— Janssen EMEA (@JanssenEMEA) October 26, 2020
Although #RSV is a common #respiratory virus, it is not well known. RSV can impact both children and adults, especially the immunocompromised. Help us share Mike’s story so more know why it’s important to seek testing this #RSVAwarenessMonth. pic.twitter.com/a3SMk3GYra
— Janssen EMEA (@JanssenEMEA) October 22, 2020
What if we combine digital therapeutics with pharmaceutical innovations? Read more from Maria Raad, VP Customer & Digital Strategy, Janssen EMEA, in @pharmaphorum: https://t.co/MebrdBBR6l
— Janssen EMEA (@JanssenEMEA) October 19, 2020
Despite progress made, #HIV remains one of the greatest global health threats of our time, with many countries being left behind due to levels of service and unpredictable funding. Find out what could help bring an end to the AIDS epidemic here https://t.co/CNbsMbRrF5
— Janssen EMEA (@JanssenEMEA) October 17, 2020
Working in digital & predictive therapeutics? What could your #healthtech achieve with 9 months of coaching from Janssen + a proving ground aimed to refine & develop your business for a European stage at @ParisBrainInst ‘s incubator iPEPS's living lab? https://t.co/293IlGlVIt pic.twitter.com/7dNPedw60h
— Janssen EMEA (@JanssenEMEA) October 13, 2020
Living with IBD can feel isolating and during this time of uncertainty, these feelings can increase. Talking about your condition can help – My IBD Journey offers practical advice for talking about your IBD https://t.co/eFIPKA3BVc #UEGWeek
— Janssen EMEA (@JanssenEMEA) October 13, 2020
#BreakingDepression uses the Japanese art of kintsugi to shine a light on what it's like to live with this devastating illness. Follow us in the run up to #WMHD2020 to see how you can help. #BreakingDepression pic.twitter.com/QugzI9XqlM
— Janssen EMEA (@JanssenEMEA) October 9, 2020
We are working towards a world where we're no longer threatened by diseases like #COVID19 & #HIV. Vaccines will play an important part in this effort. Learn more about how our tech allows us to work effectively in the fight against infectious diseases https://t.co/TjsryRyt6s
— Janssen EMEA (@JanssenEMEA) October 8, 2020
Finding preventive solutions for #COVID19 will be crucial to our chances of defeating the current global pandemic. Find out why vaccines will be key to these efforts: https://t.co/pe6VaRX6kV pic.twitter.com/tmWYjZqgkY
— Janssen EMEA (@JanssenEMEA) September 26, 2020
Max Pahlow, Vice president of Immunology at Janssen EMEA, shares his views on our work in immune-mediated inflammatory disease. We’re working hard to address patients’ therapeutic needs and minimize the day to day impact of #IMID https://t.co/rgQZ22OKA8
— Janssen EMEA (@JanssenEMEA) September 21, 2020
The future of #healthcare is ever changing but benefit of digital solutions that improve treatment decisions and enable predictive diagnostic is huge. We opened a new Startup Accelerator to help those already ahead of the curve #scaleup with pace: https://t.co/fBez0dHWZ7 pic.twitter.com/9TKpETPOnv
— Janssen EMEA (@JanssenEMEA) September 4, 2020
#WorldLeukemiaDay is on 4th September. Find out how you can get involved here 👇 👇 https://t.co/BLMCCgGYwH #SpotLeukemia #VictoriesOverCancer #BloodCancerAwarenessMonth #WLD20 pic.twitter.com/dZxVhgL48g
— Janssen EMEA (@JanssenEMEA) September 4, 2020
Our colleague Anouk De Vroey calls for a health innovation pact. Let's keep this spirit of innovation and trust, and go even further. Read her expert opinion on @pharmaforum1 : https://t.co/CjArdwjICB
— Janssen EMEA (@JanssenEMEA) August 27, 2020
We have been working toward helping those most vulnerable to #infectiousdiseases by aiming to help prevent #Ebola outbreaks before they start. Learn more about our work to fight Ebola: https://t.co/vCT7fhfwxQ pic.twitter.com/vnMIaNUL4O
— Janssen EMEA (@JanssenEMEA) July 23, 2020
Global healthcare is changing more rapidly than ever before. Our colleague @IZemzoum shares her ideas on how the system is primed for a reboot. Full article on @pharmaphorum: https://t.co/6LP81sRFug
— Janssen EMEA (@JanssenEMEA) July 13, 2020
The 6th Systemic Sclerosis World Congress kicks off virtually today. PAH is a well-recognised complication of #systemicsclerosis. We are looking forward to the scientific exchange and learning from experts to better support patients living with PAH. #wsc20 #scleroderma #SSc pic.twitter.com/5LWpIMM2VJ
— Janssen EMEA (@JanssenEMEA) July 12, 2020
Prof Eduard Vieta and Dr Daniel Souery believe that healthcare professionals need to take advantage of social media and digital platforms to improve mental health programmes. Read the full article in @POLITICOEurope here: https://t.co/tMhZRl06SP #BreakingDepression pic.twitter.com/Qb51yWCUZT
— Janssen EMEA (@JanssenEMEA) July 8, 2020
Martin Price, VP Health Economics, Market Access and Reimbursement at Janssen EMEA, joins the #DIAEurope2020 panel to discuss HTA processes for innovative cancer medicines. Join by subscribing below https://t.co/xltzh17SUn @EFPIA
— Janssen EMEA (@JanssenEMEA) June 29, 2020
How can we improve Europe's mental health services? Two leading psychiatrists, Prof . Eduard Vieta and Dr Daniel Souery, explain how greater investment in education and awareness is key in @POLITICOEurope: https://t.co/MzGHZTBiAt #BreakingDepression pic.twitter.com/w1SA11me2m
— Janssen EMEA (@JanssenEMEA) June 29, 2020
Do you know the difference between #Crohnsdisease and #ulcerativecolitis? Tomorrow is #WorldIBDDay, so take some time to learn more about how these conditions affect people’s day-to-day lives by visiting the #MyIBDJourney website https://t.co/mAjlXYGQZf #IBDvisible pic.twitter.com/IUiv8GepKn
— Janssen EMEA (@JanssenEMEA) May 18, 2020
How can Real World Evidence accelerate research? Martin Price, VP Health Economics, Market Access and Reimbursement at Janssen EMEA explains how we want to move towards a more value-based healthcare model in an interview with pharmaphorum. https://t.co/yFluQp2vLn
— Janssen EMEA (@JanssenEMEA) May 18, 2020
#COMy20 is virtual and minimal residual disease (MRD) is a hot topic. Watch Bruno Paiva, @Mohty_EBMT, Niels van de Donk & others discuss how #MRD could be used to guide #multiplemyeloma treatment: https://t.co/p0Wyc5DvDV @COMyCongress #mmsm #MRDdocumentary #MRDdoc
— Janssen EMEA (@JanssenEMEA) May 16, 2020
About 350,000 people in Europe are living with #lupus yet it is a mostly misunderstood condition. This #WorldLupusDay, we're supporting groups like @LupusEurope to help us bring #ThePEACEWithin to people living with lupus. RT our infographic and raise awareness of this condition.
— Janssen EMEA (@JanssenEMEA) May 10, 2020
Proud to be one part of our industry’s efforts in fighting #COVID19. Together with our @EFPIA partners, #WeWontRest until we beat this virus. See our efforts here: https://t.co/SraqLjhEPW #JanssenAtOurBest
— Janssen EMEA (@JanssenEMEA) April 20, 2020
When Anouk De Vroey lost her father to heart disease, she found new purpose in her working life. Discover how she works to inform policymakers across Europe of the latest medical breakthroughs and how to increase access to these treatments #wewontrest https://t.co/CM7ExjvSln pic.twitter.com/MavPl5K3Vo
— Janssen EMEA (@JanssenEMEA) March 5, 2020
It can be hard to find the words to describe depression. Artist @billiebondscul1 explains how kintsugi, an ancient Japanese art form, can help us communicate when words fail us in @POLITICOEurope: https://t.co/5cRROweLCE #BreakingDepression
— Janssen EMEA (@JanssenEMEA) March 5, 2020
Which European country is most attractive for life science investments?
See who scores highest in the “Life Science Investment Attractiveness Report”: https://t.co/Hd4HhEVY7o pic.twitter.com/KUXUn8yxgm
— Janssen EMEA (@JanssenEMEA) February 12, 2020
There are many myths surrounding psoriasis which can make preparing to see your doctor a worrisome experience. #BeInformed and know the myths from the facts this #WorldPsoriasisDay at Psoriasis 360 below
— Janssen UK (@JanssenUK) October 29, 2020
On Sept 12, 1926, Dr. Paul Janssen was born in Turnhout, Belgium. Inspired to pursue medicine after the loss of his sister, he went on to found Janssen Pharmaceutica N.V. and help revolutionise modern medicine. Happy birthday, Dr. Paul! pic.twitter.com/1Cv4PYNA38
— Janssen UK (@JanssenUK) September 12, 2020
We are committed to building #partnerships that can make a difference to the lives of patients. Last year, we began a collaboration with @NHS Wales and the @WelshGovernment to build data solutions to improve outcomes for #bloodcancer patients pic.twitter.com/4MuFQI1GkP
— Janssen UK (@JanssenUK) September 8, 2020
In recent decades, the relationship between #pharma and #patients has transformed – patients are now present at every stage of the pharma journey. Here Amanda Cunnington explains the importance of #patientcentricity in all that we do at Janssen UK.
— Janssen UK (@JanssenUK) September 7, 2020
#Medicalresearch charities play a critical role in enriching and progressing the UK Life Sciences sector. #JNJ stands with @AMRC in their call to preserve charity-funded #research the amidst the COVID-19 crisis https://t.co/wjWF9IIS9G
— Janssen UK (@JanssenUK) September 2, 2020
How can partnerships stemming from #COVID19 improve future health policy and support and enable #innovation? How can we better equip healthcare systems for the future? Janssen EMEA’s Anouk De Vroey shared her insights with @pharmaphorum
— Janssen UK (@JanssenUK) August 27, 2020
Since the onset of #COVID-19, #JNJ has been dedicated to the fight this pandemic. From our accelerated vaccine development efforts, to supporting the healthcare frontline. Find out more about our response here: https://t.co/mRYWjBYSEU
— Janssen UK (@JanssenUK) July 20, 2020
At @JanssenUK we are delighted to have been recognised for our ‘Not Every Disease is Visible’ Campaign in partnership with @CrohnsColitisUK with support from @Evolekyne. To learn more about the campaign please visit: https://t.co/9tJlXeyDwt https://t.co/yZIj0FrpJn
— Janssen UK (@JanssenUK) July 6, 2020
Pharmaceutical companies are working globally to combat #COVID19. As part of our efforts, we recently announced an update on our strides towards accelerating the development of a vaccine, with trials to start next month. Find out more about the industry’s progress: https://t.co/GhGCPfFqRz
— Janssen UK (@JanssenUK) June 24, 2020
As part of #JNJ, we are committed to tackling the #COVID19 pandemic head on, while keeping patients at the centre of our decision making. Our MD, Gaetan Leblay, has spoken with @pharmaphorum about playing our part in the fight against #coronavirus https://t.co/WrMmnhSKMG
— Janssen UK (@JanssenUK) May 19, 2020
Are you or a loved one living with blood cancer? Check out this series of helpful videos on wellbeing, diet and support https://t.co/J04kGfs23F #BCAM #MakeBloodCancerVisible
— Janssen Ireland (@JanssenIE) September 25, 2020
Medicines help us live longer & tackle disease. Even though many medicines are made in Ireland, patients here are among the last in western Europe to get them. @IPHA invites Government to jointly fund with industry the cost of new medicines through collaboration. pic.twitter.com/L8LBzLjB75
— Janssen Ireland (@JanssenIE) September 24, 2020
— Janssen Ireland (@JanssenIE) September 22, 2020
Professional rugby player, @john_ryan_88 tells his story of managing a professional sporting career with IBD. Listen back to ep 7 to hear more. #Gutcast @ISCCIRL
— Janssen Ireland (@JanssenIE) August 20, 2020
Applying for graduate programmes? Ross Parsons, early-talent recruitment lead for the UK and Ireland at Johnson & Johnson, explains what his company is looking for and what new hires can expect https://t.co/4MuQN6hIBa
— Silicon Republic (@siliconrepublic) October 27, 2020
How to make diversity and inclusion ‘part of your company DNA’ https://t.co/3gKDM7EePz
— Silicon Republic (@siliconrepublic) October 16, 2020
The @RCSI_Irl has announced a new partnership led by the university’s researchers that aims to advance predictive tests for multiple myeloma, which is the second most common blood cancer in Ireland. https://t.co/k7LQQkPTwO
— Silicon Republic (@siliconrepublic) September 18, 2020
For a company such as @JNJNews, not everyone can work from home during a pandemic. In its Irish business, this meant a ‘very agile operational model’ had to be introduced. https://t.co/Oo065x24bs
— Silicon Republic (@siliconrepublic) September 7, 2020
“This is an area where you have the opportunity to directly influence and improve how care is delivered.” – @JNJNews' Brendan Cosgrave https://t.co/bklwKj1p4t
— Silicon Republic (@siliconrepublic) September 3, 2020
J&J’s Leisha Daly: ‘The digital revolution is impacting many areas of our business’ https://t.co/NHunqgenuC
— Silicon Republic (@siliconrepublic) June 23, 2020
J&J Announces Agreement in Principle with Government of
Canada to Supply its #COVID19 Vaccine Candidate. Read more here: https://t.co/ipSgF4y65Q pic.twitter.com/nvZhN5iY20— Janssen Canada (@JanssenCanada) August 31, 2020
Congratulations to all the awardees! We’re proud to be a partner in this important scholarship and mentorship program. https://t.co/Tx9pDHM3dI
— Janssen Canada (@JanssenCanada) July 10, 2020
Congratulations, Carolina and all the other winners of the J&J #WiSTEM2D Scholars Award. #WomenInSTEM https://t.co/wFnXw438Ka
— Janssen Canada (@JanssenCanada) July 7, 2020
When developing new medicines and #vaccines, tens of thousands of compounds are screened, with only 5 making it to #clinicaltrials. Learn more about the process of bringing innovative medicines to Canadians. https://t.co/t6aJcwFj2y pic.twitter.com/rFnKtIhXGi
— Innovative Medicines Canada (@innovativemeds) October 4, 2020
#DYK that pharmaceutical prices in Canada are already below the global median and have declined to the lowest they have ever been in the history of PMPRB? Find out more in our PMPRB Myth-Busting document 👇https://t.co/ZENTP9EtnD
— Innovative Medicines Canada (@innovativemeds) September 6, 2020
"We are in this together" – #JnJ's Paul Kershaw speaks to Radio NZ about a COVID-19 vaccinehttps://t.co/oxdb2EBszD
— Janssen ANZ (@JanssenANZ) April 8, 2020
Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson talks on COVID-19 including progress on a vaccine https://t.co/n9cDRdUbcB via @theage
— Janssen ANZ (@JanssenANZ) April 6, 2020
Dear Australia, your health is essential! Don’t delay your routine healthcare-even during COVID-19 #DontWaitMate pic.twitter.com/tfWkP8Vnm7
— Medicines Australia (@MedicinesAus) September 25, 2020
Each year the pharmaceutical industry registers hundreds of new #ClinicalTrials in Australia, supporting thousands of jobs and improving the health of Australians. This will continue to be crucial as we navigate our way through the #COVID19 pandemic. #MedicinesMatter pic.twitter.com/V93WjYmegS
— Medicines Australia (@MedicinesAus) July 3, 2020
An exciting new R&D agreement between @McIntosh_AUS and her team with @JNJGlobalHealth to advance the development of inhaled oxytocin, a novel medicine that could save women's lives in childbirth. @JNJInnovationhttps://t.co/K7xFliLOE4
— MIPS (@MIPS_Australia) August 4, 2020
Celebrating the legacy of our founder, Dr. Paul Janssen as we share our Janssen story 📽 pic.twitter.com/qSQJ2buZhT
— Janssen Asia Pacific (@JanssenAP) September 11, 2018
At #Janssen we’re committed to the research and development of vaccines to protect people of all ages against disease. #VaccinesWork pic.twitter.com/tX69IS6uLl
— Janssen Global (@JanssenGlobal) April 24, 2020
In honor of #InternationalNursesDay, Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, writes about the invaluable work of nurses, especially in the fight against #COVID19. Read the article: https://t.co/Z8dutZeE8P
— Janssen Global (@JanssenGlobal) May 12, 2020
On #ICTD2020, we celebrate patients, scientists & researchers that take part in #clinicaltrials helping to bring new treatments to patients. Follow #WeWontRest to see how the pharmaceutical industry is working tirelessly to ensure the continuity of clinical trials during #COVID19 pic.twitter.com/9EjC0on1O3
— EFPIA (@EFPIA) May 20, 2020
#JNJ is proud to share our commitment to upholding the integrity of the scientific process in the development of a #COVID19 vaccine. Rigorous science and safety must be the priority in vaccine development. #WeStandWithScience, and encourage @AstraZeneca to stand with us. https://t.co/3NnE2QmYh0 pic.twitter.com/XtosCUH5DR
— Johnson & Johnson (@JNJNews) September 8, 2020
The #COVID19 response calls for increased training & education for health workers. That's why #JNJ is partnering with World Continuing Education Alliance, @AKUGlobal and @ICNurses to #BackTheFrontline and reach 600K frontliners across Africa. Hear more from VP Luis Diaz Rubio: pic.twitter.com/qSaxOSUFpo
— Johnson & Johnson Global Health (@JNJGlobalHealth) June 10, 2020
#COVID19 knows no borders. That's why we've deepened our partnership with @ifrc to support on-going needs across EMEA of those serving on the frontlines. Hear from #JNJ's Pat Smallcombe on how we #BacktheFrontline with our partners👇 pic.twitter.com/ZtwcIgnMnx
— Johnson & Johnson Global Health (@JNJGlobalHealth) May 13, 2020
Around the world, we’re stepping up to #BacktheFrontline. @JanssenEMEA's Chairman, Kris Sterkens announces €5M to support the immediate needs for frontline health workers in hardest-hit communities in Europe, the Middle East and Africa. pic.twitter.com/FNM6X2Potd
— Johnson & Johnson Global Health (@JNJGlobalHealth) April 22, 2020